Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 170   

Articles published

AZN 4,757.14 +12.28 (0.26%)
price chart
AstraZeneca offloads remaining rights to anaesthetic portfolio to Aspen for US ...
Drugs giant AstraZeneca PLC (LON:AZN) has agreed to offload the remaining rights to its anaesthetic medicines to a division of Aspen Group for up to US$766mln.
Aspen buys remaining AstraZeneca anesthetic rights  MarketWatch
TOP NEWS: AstraZeneca Sells Remaining Anaesthetic Rights To Aspen  Interactive Investor
AstraZeneca gains after reporting positive results from two trials of lung ...
Pharmaceuticals company AstraZeneca PLC (LON:AZN) shares rose after saying it has achieved positive results from two separate phase III trials of lung cancer drugs Imfinzi and Tagrisso.
AstraZeneca, Merck and Inctye show cancer treatment advances  Financial Times
AstraZeneca: Positive results in 2 cancer trials  MarketWatch
Why I'd ditch this defensive dividend stock to buy AstraZeneca plc
Dairy Crest (LSE: DCG) today reported a “strong first half of the year” in a pre-close trading update for the six months to 30 September.
AstraZeneca gets regulatory green light for breast cancer drug
Some good news for AstraZeneca PLC (LON:AZN), which said the US Food and Drug Administration (FDA) has approved Faslodex for wider use in women with breast cancer.
Natixis upgrades AstraZeneca to 'buy' on prospect of positive results from key ...
French broker Natixis has upgraded its rating for AstraZeneca PLC (LON:AZN) to 'buy' from 'neutral' as its analysts feel the prospect of positive results from the group's key MYSTIC lung cancer trial gives the blue chip drugmaker “an asymmetric risk ...
AstraZeneca plc's (LON:AZN) Hold Rating Reaffirmed at Shore Capital  The Ledger Gazette
High-Yield Dividend Stock to Target:: AstraZeneca PLC (AZN)  Voice Of Analysts
Implied Volatility Surging for AstraZeneca (AZN) Stock Options
Clearly, options traders are pricing in a big move for AstraZeneca shares, but what is the fundamental picture for the company?
How does AstraZeneca PLC (LSE:AZN) fare as a dividend stock?
Over the past 10 years AstraZeneca PLC (LSE:AZN) has returned an average of 4.66% per year from dividend payouts. The stock now yields roughly 4.52% with a market cap of �82.37 Billion.
AstraZeneca plc (AZN) Rating Reiterated by Citigroup Inc.  The Ledger Gazette
AstraZeneca plc (AZN) Receives Average Recommendation of “Hold” from ...  Dispatch Tribunal
AstraZeneca plc (LON:AZN) Receives “Hold” Rating from Shore Capital
AstraZeneca plc logo AstraZeneca plc (LON:AZN)'s stock had its “hold” rating reissued by Shore Capital in a research report issued on Monday, September 11th.
Astrazeneca PLC (NYSE:AZN) Closed Higher Than Its 50 Day Moving Average  Highlight Press
Will This Stock Pay Off? Technicals Update on AstraZeneca PLC (AZN.L)  Concord Register
AstraZeneca shares advance on positive lung drug results
Drug maker AstraZeneca Plc (LON:AZN) was boosted, with shares up more than 2%, as it revealed positive test results allowing it to advance a lung disease treatment towards US FDA approval in the first half of 2018.
Does GlaxoSmithKline plc offer more investment potential than AstraZeneca plc ...
That's a disappointing result in my view, and is behind the performance of some of its healthcare sector peers such as AstraZeneca plc (LON:AZN) (AZN.L), Shire PLC (LON:SHP) (SHP.L) and Hikma Pharmaceuticals Plc (LON:HIK) (HIK.L). The AstraZeneca ...